Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IKAROS family zinc finger 1 | 0.533 | 0.769 | 1.00 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2008 | 2013 | ||||||||
|
paired box 5 | 0.487 | 0.654 | 1.00 |
|
disease | 0.350 | None | 1.000 | 4 | 0 | 2003 | 2019 | ||||||||
|
GATA binding protein 3 | 0.415 | 0.846 | 0.90 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2013 | 2013 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1995 | 2017 | ||||||||
|
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 0.647 | 0.423 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 1985 | 2017 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.400 | None | 0.984 | 1 | 0 | 1990 | 2019 | ||||||||
|
immunoglobulin heavy locus | 0.473 | 0.654 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1991 | 2020 | |||||||||
|
HLF transcription factor, PAR bZIP family member | 0.628 | 0.615 | 0.95 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 1993 | 2017 | ||||||||
|
activator of transcription and developmental regulator AUTS2 | 0.569 | 0.846 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
forkhead box P1 | 0.460 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
PBX homeobox 1 | 0.534 | 0.846 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1990 | 2007 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 1.000 | None | 0.977 | 0 | 0 | 1982 | 2020 | ||||||||
|
AF4/FMR2 family member 1 | 0.659 | 0.423 | 0.71 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
transcription factor 3 | 0.476 | 0.846 | 2.6E-02 |
|
disease | 0.580 | None | 1.000 | 0 | 0 | 1990 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.320 | None | 1.000 | 0 | 0 | 1998 | 2005 |